|
|
Volumn 94, Issue 5, 2002, Pages 324-326
|
|
Battle over generic Taxol concludes, but controversy continues
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CASTOR OIL;
GENERIC DRUG;
PACLITAXEL;
ANTINEOPLASTIC ACTIVITY;
CLINICAL STUDY;
CONTROLLED STUDY;
DRUG APPROVAL;
DRUG BINDING;
DRUG COST;
DRUG EFFICACY;
DRUG ISOLATION;
DRUG MARKETING;
DRUG STRUCTURE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
NOTE;
OVARY CANCER;
PATENT;
PRIORITY JOURNAL;
|
|
EID: 0037029022
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.5.324 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|